European Heart Journal Advance Access published online on October 4, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi505
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atrial fibrillation management: a prospective survey in ESC Member Countries The Euro Heart Survey on Atrial Fibrillation
1 Department of Cardiology, University Hospital Maastricht, P. Debyelaan 25, PO Box 5800, Maastricht 6202AZ, Maastricht, The Netherlands
* To whom correspondence should be addressed. Aims To describe atrial fibrillation (AF) management in member countries of the European Society of Cardiology (ESC) and to verify cardiology practices against guidelines. Methods and results Among 182 hospitals in 35 countries, 5333 ambulant and hospitalized AF patients were enrolled, in 2003 and 2004. AF was primary or secondary diagnosis, and was confirmed on ECG in the preceding 12 months. Clinical type of AF was reported to be first detected in 978, paroxysmal in 1517, persistent in 1167, and permanent in 1547 patients. Concomitant diseases were present in 90% of all patients, causing risk factors for stroke to be also highly prevalent (86%). As many as 69% of patients were symptomatic at the time of the survey; among asymptomatic patients, 54% were previously experienced symptoms. Oral anticoagulation was prescribed in 67 and 49% of eligible and ineligible patients, respectively. A rhythm control strategy was applied in 67% of currently symptomatic patients and in 44% of patients who never experienced symptoms. Conclusion This survey provides a unique snapshot of current AF management in ESC member countries. Discordance between guidelines and practice was found regarding several issues on stroke prevention and antiarrhythmic therapy.
Received March 30, 2005
Revised August 26, 2005
Accepted September 2, 2005
Clinical research
2 Department of Cardiology, Guglielmo da Saliceto Hospital, Piacenza, Italy
3 Department of Cardiology, St George's Hospital, London, UK
4 Department of Cardiology, University Hospital Lund, Lund, Sweden
5 Department of Cardiology, Krankenhaus am Urban, Berlin, Germany
6 Department of Cardiology, St Mary's Hospital, London, UK
7 Department of Medical Cardiology, Royal Infirmary, Glasgow, UK
8 Department of Cardiology and Angiology, University Hospital Münster, Münster, Germany
9 Department of Cardiology, Hopital European Georges Pompidou, Paris, France
10 Department of Clinical Epidemiology and Medical Technology Assessment, University Hospital Maastricht, Maastricht, The Netherlands
11 Division of Cardiology, Centre Hospitalier Universitaire Nord, Marseille, France
Robby Nieuwlaat, E-mail: r.nieuwlaat{at}cardio.azm.nl
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. H. Hohnloser, G. Z. Duray, U. Baber, and J. L. Halperin Prevention of stroke in patients with atrial fibrillation: current strategies and future directions Eur. Heart J. Suppl., September 1, 2008; 10(suppl_H): H4 - H10. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F Tops and M. J Schalij Multislice CT: is it essential before atrial fibrillation ablation? Heart, August 1, 2008; 94(8): 973 - 975. [Full Text] [PDF] |
||||
![]() |
A. Meiltz, M. Zimmermann, P. Urban, A. Bloch, and on behalf of the Association of Cardiologists of t Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world Europace, June 1, 2008; 10(6): 674 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nieuwlaat, M. H. Prins, J.-Y. Le Heuzey, P. E. Vardas, E. Aliot, M. Santini, S. M. Cobbe, J. W.M.G. Widdershoven, L. H. Baur, S. Levy, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation Eur. Heart J., May 1, 2008; 29(9): 1181 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Kojodjojo, T Wong, A R Wright, O M Kon, W Oldfield, P Kanagaratnam, D W Davies, and N S Peters Pulmonary venous stenosis after treatment for atrial fibrillation BMJ, April 12, 2008; 336(7648): 830 - 832. [Full Text] [PDF] |
||||
![]() |
R. Nieuwlaat, T. Dinh, S. B. Olsson, A. J. Camm, A. Capucci, R. G. Tieleman, G. Y.H. Lip, H. J.G.M. Crijns, and on behalf of the Euro Heart Survey Investigators Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur. Heart J., April 1, 2008; 29(7): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Hansen, N. Gadsboll, G. H. Gislason, S. Z. Abildstrom, T. K. Schramm, F. Folke, J. Friberg, R. Sorensen, S. Rasmussen, H. E. Poulsen, et al. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers Europace, April 1, 2008; 10(4): 395 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ringborg, R. Nieuwlaat, P. Lindgren, B. Jonsson, D. Fidan, A. P. Maggioni, J. Lopez-Sendon, J. Stepinska, D. V. Cokkinos, and H. J.G.M. Crijns Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation Europace, April 1, 2008; 10(4): 403 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. de Vos, R. Nieuwlaat, H. J.G.M. Crijns, A. J. Camm, J.-Y. LeHeuzey, C. J. Kirchhof, A. Capucci, G. Breithardt, P. E. Vardas, R. Pisters, et al. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey Eur. Heart J., March 1, 2008; 29(5): 632 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace, January 1, 2008; 10(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nieuwlaat, L. W. Eurlings, A. Capucci, and H. J.G.M. Crijns Atrial fibrillation in the 'real world': undecided issues Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I122 - I128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lamotte, L. Annemans, B. Bridgewater, S. Kendall, and M. Siebert A health economic evaluation of concomitant surgical ablation for atrial fibrillation Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 702 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jais and D. L. Packer Ablation vs. drug use for atrial fibrillation Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G26 - G34. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Wyse Bleeding While Starting Anticoagulation for Thromboembolism Prophylaxis in Elderly Patients With Atrial Fibrillation: From Bad to Worse Circulation, May 29, 2007; 115(21): 2684 - 2686. [Full Text] [PDF] |
||||
![]() |
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart, May 1, 2007; 93(5): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Caterina, S. Husted, L. Wallentin, G. Agnelli, F. Bachmann, C. Baigent, J. Jespersen, S. D. Kristensen, G. Montalescot, A. Siegbahn, et al. Anticoagulants in heart disease: current status and perspectives Eur. Heart J., April 10, 2007; (2007) ehl492v1. [Full Text] [PDF] |
||||
![]() |
E. Bertaglia, G. Stabile, G. Senatore, A. Colella, M. Del Greco, H. Goessinger, F. Lamberti, M. Lowe, R. Mantovan, N. Peters, et al. A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study) Europace, March 1, 2007; 9(3): 182 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dagres, R. Nieuwlaat, P. E. Vardas, D. Andresen, S. Levy, S. Cobbe, D. Th. Kremastinos, G. Breithardt, D. V. Cokkinos, and H. J.G.M. Crijns Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation J. Am. Coll. Cardiol., February 6, 2007; 49(5): 572 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R I Dewar, G Y H Lip, and on behalf of the Guidelines Development Group for Identification, diagnosis and assessment of atrial fibrillation Heart, January 1, 2007; 93(1): 25 - 28. [Full Text] [PDF] |
||||
![]() |
R. Nieuwlaat, A. Capucci, G. Y.H. Lip, S. B. Olsson, M. H. Prins, F. H. Nieman, J. Lopez-Sendon, P. E. Vardas, E. Aliot, M. Santini, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur. Heart J., December 2, 2006; 27(24): 3018 - 3026. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof and U. Schotten Hypertension begets hypertrophy begets atrial fibrillation? Insights from yet another sheep model Eur. Heart J., December 2, 2006; 27(24): 2919 - 2920. [Full Text] [PDF] |
||||
![]() |
F. Holmqvist, M. Stridh, J. E.P. Waktare, L. Sornmo, S. B. Olsson, and C. J. Meurling Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation Eur. Heart J., September 2, 2006; 27(18): 2201 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF] |
||||
![]() |
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF] |
||||
![]() |
G. Boriani, I. Diemberger, C. Martignani, M. Biffi, and A. Branzi The epidemiological burden of atrial fibrillation: a challenge for clinicians and health care systems Eur. Heart J., April 2, 2006; 27(8): 893 - 894. [Full Text] [PDF] |
||||
![]() |
D. G. Wyse The Euro Heart Survey on atrial fibrillation: a picture and a thousand words Eur. Heart J., November 2, 2005; 26(22): 2356 - 2357. [Full Text] [PDF] |
||||







